(Q30381923)

English

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

immune responsiveness

1 reference

based on heuristic

inferred from title

François Roman

5

object named as

François Roman

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

7

object named as

Paul Gillard

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

6

object named as

Mamadou Dramé

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Tino F Schwarz

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Thomas Horacek

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Markus Knuf

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Hanns-Gerd Damman

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Wolfgang Jilg

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

1 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

6284-6290

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Avian influenza virus (H5N1): a threat to human health.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Human infection with highly pathogenic H5N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Update on avian influenza A (H5N1) virus infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Mitigation strategies for pandemic influenza in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Strategies for mitigating an influenza pandemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Pre- or post-pandemic influenza vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Pandemic H5N1 influenza vaccine development: an update.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.040

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.01.040

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30381923&oldid=1549962827"